Alexander T. Pearson

Alexander Pearson practices at Comer Children's Hospital - Hyde Park in Chicago, Illinois.

Alexander Pearson's NPI, 1134448665, was assigned on May 24, 2010. Alexander Pearson graduated from University of Rochester School of Medicine and Dentistry in 2010. Alexander Pearson holds Illinois license 036143870.

Alexander Pearson's primary practice is Comer Children's Hospital - Hyde Park, at 5721 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

Alexander Pearson's primary practice is Comer Children's Hospital - Hyde Park in Chicago, Illinois. Alexander Pearson is also affiliated with University of Chicago Medical Center. The medical group on file is UChicago Medicine Physicians. Dmand AI also links Alexander Pearson to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Alexander Pearson practices, 2 sites in all. Vendor and product names are available with a free account.

Medical oncology is Alexander Pearson's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Alexander Pearson is licensed in Illinois.

CMS data shows 260 Medicare services from Alexander Pearson across 6 procedure codes in 2024, for 90 Medicare patients. Medicare paid $18,727 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 90 Medicare patients who saw Alexander Pearson in 2024. The largest group is 65 to 74, with 48 patients. 72% of them have high blood pressure, and 63% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Alexander Pearson's median patient age at 72, with 35% women.

In 2024, Alexander Pearson wrote 71 Medicare Part D claims for 26 patients. 80% of them were for generic drugs. CMS names the drug for 32 of them, across 2 drugs with 11 or more claims each, at $544 in total drug cost. In 2023, CMS named 25 claims across 1 drug.

Alexander Pearson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Alexander Pearson as offering telehealth.

Dmand AI links 120 papers to Alexander Pearson, published from 2015 to 2025. 2023 was the busiest year, with 18. The most frequent topics are Head and Neck Neoplasms, Deep Learning and Cell Line, Tumor. Alexander Pearson has published most often in Oral Oncol. Alexander Pearson's most frequent co-authors are Frederick Matthew Howard, MD, Nishant Agrawal and Ari Joseph Rosenberg, MD.

Dmand AI links Alexander Pearson to 4 clinical trials, 2 of them phase 1/2 studies. Conditions studied include Carcinoma, Merkel Cell, Oropharyngeal Neoplasms and Salivary Gland Neoplasms.

CMS Open Payments shows 11 general payments to Alexander Pearson from 2 drug and device companies from 2023 to 2025. Consulting fees make up the largest share, 95% of the total. Daiichi Sankyo Inc. paid the most, $11,344.

Alexander Pearson graduated from University of Rochester School of Medicine and Dentistry in 2010.